NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Oct 31 2025

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-31-2025-15

Natco Pharma Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases